EQL Pharma's Chief Commercial Officer (CCO) Alexander Brising has recently sold shares for approximately SEK 2.1 million to pay for an apartment for his daughter who is starting university. "Not a decision I took lightly as I strongly believe in EQL where I have been a contributor to the success of the last nine years and I myself am one of the main authors of both previous plans and the new five-year plan. There are many exciting things in the pipeline. But the daughter could not find anywhere to live so it was not much of a choice in the end. Family has to come first."